" class="no-js "lang="en-US"> Industry News Archives - Medtech Alert
Saturday, April 01, 2023

Sort by:

Date

Top Post

Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience

Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]

Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions

Flare Therapeutics, a biotechnology company targeting transcription factors to discover precision medicines for cancer and […]

Sensorion Appoints Khalil Barrage as Interim Chairman of the Board

Sensorion, a pioneering clinical-stage biotechnology company that specializes in gene therapies in the ear, announces […]

Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors

Glyscend Therapeutics, a clinical-stage biotechnology company pioneering a new generation of orally administered polymer therapies, […]

Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases

Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today […]

Xeris Biopharma Appoints Ricki Fairley to Board of Directors

Xeris Biopharma, a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing […]

Genialis Raises $13M in Financing to Build Clinical Biomarkers that Predict Patient Response

Genialis, a computational precision medicine company unraveling complex biology to find new ways to address […]

MIMETAS and Astellas Enter into Strategic Partnership

MIMETAS, a global leader in human disease modeling, announces that it has entered into a […]

Ratio Therapeutics Announces Licensing Agreement for Investigational PET Imaging Agent with Merck

Ratio Therapeutics, a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class […]

Sonoma Biotherapeutics and Regeneron Announce Collaboration to Discover, Develop and Commercialize T Cell Therapies

Sonoma Biotherapeutics and Regeneron Pharmaceuticals today announced a collaboration to apply their scientific and clinical expertise […]

Avacta Appoints Karen Harrison as Chief Operating Officer for Therapeutics Division

Avacta Group, a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, today […]

  1. Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis Read more
  2. NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business Read more
  3. Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions Read more
  4. Sensorion Appoints Khalil Barrage as Interim Chairman of the Board Read more
  5. Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China Read more